25 XP   0   0   10

ZhuZhou QianJin Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse ZhuZhou QianJin Pharmaceutical Co Ltd together

PenkeI guess you are interested in ZhuZhou QianJin Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ZhuZhou QianJin Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ZhuZhou QianJin Pharmaceutical Co Ltd

I send you an email if I find something interesting about ZhuZhou QianJin Pharmaceutical Co Ltd.

Quick analysis of ZhuZhou QianJin Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of ZhuZhou QianJin Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.12
When do you have the money?
1 year
How often do you get paid?
97.5%

What is your share worth?

Current worth
¥6.72
Expected worth in 1 year
¥7.26
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
¥1.40
Return On Investment
13.0%

For what price can you sell your share?

Current Price per Share
¥10.80
Expected price per share
¥9.86 - ¥11.02
How sure are you?
50%

1. Valuation of ZhuZhou QianJin Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥10.80

Intrinsic Value Per Share

¥10.50 - ¥27.11

Total Value Per Share

¥17.21 - ¥33.82

2. Growth of ZhuZhou QianJin Pharmaceutical Co Ltd (5 min.)




Is ZhuZhou QianJin Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$399.1m$369m$24m6.1%

How much money is ZhuZhou QianJin Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$10.8m$10.3m$460.8k4.3%
Net Profit Margin7.9%7.7%--

How much money comes from the company's main activities?

3. Financial Health of ZhuZhou QianJin Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of ZhuZhou QianJin Pharmaceutical Co Ltd? (5 min.)

Welcome investor! ZhuZhou QianJin Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of ZhuZhou QianJin Pharmaceutical Co Ltd.

What can you expect buying and holding a share of ZhuZhou QianJin Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of ZhuZhou QianJin Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of ZhuZhou QianJin Pharmaceutical Co Ltd is ¥10.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ZhuZhou QianJin Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ZhuZhou QianJin Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.72. Based on the TTM, the Book Value Change Per Share is ¥0.14 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.21 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ZhuZhou QianJin Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.2%0.020.2%0.020.2%0.020.2%0.020.2%
Usd Book Value Change Per Share0.030.3%0.020.2%0.010.1%0.010.1%0.010.1%
Usd Dividend Per Share0.020.1%0.030.3%0.030.3%0.030.2%0.020.2%
Usd Total Gains Per Share0.050.4%0.050.4%0.040.3%0.030.3%0.030.3%
Usd Price Per Share1.57-1.52-1.52-1.35-1.71-
Price to Earnings Ratio15.18-15.79-18.23-16.43-38.73-
Price-to-Total Gains Ratio32.45-107.74-59.23-67.84-123.29-
Price to Book Ratio1.69-1.66-1.76-1.58-2.65-
Price-to-Total Gains Ratio32.45-107.74-59.23-67.84-123.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.49472
Number of shares669
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.03
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.050.03
Gains per Quarter (669 shares)32.3923.13
Gains per Year (669 shares)129.5492.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
17950120672583
215810125013451176
323715138020176269
4317202510268102362
5396252640335127455
6475302770403153548
7554353900470178641
86334031030537203734
97124531160604229827
107925041290671254920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%79.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%30.010.00.075.0%60.019.00.075.9%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%19.00.01.095.0%39.00.01.097.5%72.00.07.091.1%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.02.00.095.0%74.05.00.093.7%

Fundamentals of ZhuZhou QianJin Pharmaceutical Co Ltd

About ZhuZhou QianJin Pharmaceutical Co Ltd

ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, produces, and sells Chinese patent medicines, chemical medicines, and feminine hygiene products in China. The company offers traditional Chinese medicine products, including fuke qianjin capsules, chunru gel, buxue yimu pills and granules, fuke duanhongyin capsules, yimu granules, qianjin zhidai pills, fuke tiaojing tablets, jiawei xiaoyao pills, rupikang capsules, lingzhi syrup, xiao'er ganmao granules, fenghan ganmao granules, shujin fengshi medicinal liquor, and shiguogong medicinal liquor; and women's health derivatives, such as qianjin jingya sanitary napkin, qianjin run washing, and care series, etc. It also provides hygienic products, including gynaecological nursing, maternity pad/ maternity package, and baby nursing. In addition, the company provides ginger tea and wine. Additionally, it covers gynecology, cardiovascular system, endocrine system, nervous, antiviral, psychiatric, tonic, and other fields. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 and is headquartered in Zhuzhou, China.

Fundamental data was last updated by Penke on 2024-03-26 17:54:08.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of ZhuZhou QianJin Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ZhuZhou QianJin Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare ZhuZhou QianJin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.3% means that ¥0.09 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The MRQ is 9.3%. The company is making a profit. +1
  • The TTM is 7.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.3%TTM7.9%+1.3%
TTM7.9%YOY7.7%+0.3%
TTM7.9%5Y8.0%-0.1%
5Y8.0%10Y6.6%+1.4%
1.1.2. Return on Assets

Shows how efficient ZhuZhou QianJin Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ZhuZhou QianJin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.8% Return on Assets means that ZhuZhou QianJin Pharmaceutical Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The MRQ is 1.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.7%+0.0%
TTM1.7%YOY1.8%-0.1%
TTM1.7%5Y1.9%-0.1%
5Y1.9%10Y1.6%+0.3%
1.1.3. Return on Equity

Shows how efficient ZhuZhou QianJin Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ZhuZhou QianJin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.5% Return on Equity means ZhuZhou QianJin Pharmaceutical Co Ltd generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The MRQ is 3.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.5%TTM3.5%+0.0%
TTM3.5%YOY3.6%0.0%
TTM3.5%5Y3.5%0.0%
5Y3.5%10Y3.0%+0.6%

1.2. Operating Efficiency of ZhuZhou QianJin Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ZhuZhou QianJin Pharmaceutical Co Ltd is operating .

  • Measures how much profit ZhuZhou QianJin Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ZhuZhou QianJin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.3%-2.3%
TTM2.3%YOY10.7%-8.4%
TTM2.3%5Y8.7%-6.4%
5Y8.7%10Y4.7%+4.0%
1.2.2. Operating Ratio

Measures how efficient ZhuZhou QianJin Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.41 means that the operating costs are ¥1.41 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The MRQ is 1.408. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.447. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.408TTM1.447-0.038
TTM1.447YOY1.464-0.018
TTM1.4475Y1.454-0.008
5Y1.45410Y1.037+0.417

1.3. Liquidity of ZhuZhou QianJin Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if ZhuZhou QianJin Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.25 means the company has ¥2.25 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The MRQ is 2.246. The company is able to pay all its short-term debts. +1
  • The TTM is 2.182. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.246TTM2.182+0.064
TTM2.182YOY2.209-0.027
TTM2.1825Y2.333-0.151
5Y2.33310Y1.295+1.038
1.3.2. Quick Ratio

Measures if ZhuZhou QianJin Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ZhuZhou QianJin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.25 means the company can pay off ¥0.25 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The MRQ is 0.250. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.446. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.250TTM0.446-0.196
TTM0.446YOY1.167-0.721
TTM0.4465Y0.871-0.425
5Y0.87110Y0.931-0.060

1.4. Solvency of ZhuZhou QianJin Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ZhuZhou QianJin Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ZhuZhou QianJin Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.36 means that ZhuZhou QianJin Pharmaceutical Co Ltd assets are financed with 35.8% credit (debt) and the remaining percentage (100% - 35.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The MRQ is 0.358. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.369. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.358TTM0.369-0.011
TTM0.369YOY0.361+0.008
TTM0.3695Y0.349+0.020
5Y0.34910Y0.340+0.009
1.4.2. Debt to Equity Ratio

Measures if ZhuZhou QianJin Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ZhuZhou QianJin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 70.5% means that company has ¥0.71 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The MRQ is 0.705. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.742. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.705TTM0.742-0.037
TTM0.742YOY0.715+0.027
TTM0.7425Y0.665+0.077
5Y0.66510Y0.632+0.034

2. Market Valuation of ZhuZhou QianJin Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings ZhuZhou QianJin Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare ZhuZhou QianJin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 15.18 means the investor is paying ¥15.18 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The EOD is 14.455. Based on the earnings, the company is underpriced. +1
  • The MRQ is 15.178. Based on the earnings, the company is fair priced.
  • The TTM is 15.791. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD14.455MRQ15.178-0.723
MRQ15.178TTM15.791-0.614
TTM15.791YOY18.235-2.443
TTM15.7915Y16.429-0.638
5Y16.42910Y38.725-22.296
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The EOD is 6.510. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.836. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 5.409. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.510MRQ6.836-0.326
MRQ6.836TTM5.409+1.427
TTM5.409YOY1.799+3.609
TTM5.4095Y8.999-3.591
5Y8.99910Y16.275-7.275
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ZhuZhou QianJin Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of ZhuZhou QianJin Pharmaceutical Co Ltd:

  • The EOD is 1.608. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.688. Based on the equity, the company is underpriced. +1
  • The TTM is 1.658. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.608MRQ1.688-0.080
MRQ1.688TTM1.658+0.030
TTM1.658YOY1.763-0.105
TTM1.6585Y1.580+0.078
5Y1.58010Y2.653-1.073
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ZhuZhou QianJin Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2330.136+71%0.059+295%0.069+239%0.103+127%
Book Value Per Share--6.7176.613+2%6.207+8%6.146+9%5.198+29%
Current Ratio--2.2462.182+3%2.209+2%2.333-4%1.295+73%
Debt To Asset Ratio--0.3580.369-3%0.361-1%0.349+3%0.340+5%
Debt To Equity Ratio--0.7050.742-5%0.715-1%0.665+6%0.632+12%
Dividend Per Share--0.1170.214-45%0.213-45%0.181-36%0.142-18%
Eps--0.1870.174+7%0.175+7%0.174+7%0.131+43%
Free Cash Flow Per Share--0.4150.194+113%0.301+38%0.206+101%0.193+115%
Free Cash Flow To Equity Per Share--0.415-0.053+113%0.066+530%0.018+2192%0.140+195%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--27.106--------
Intrinsic Value_10Y_min--10.496--------
Intrinsic Value_1Y_max--1.327--------
Intrinsic Value_1Y_min--0.825--------
Intrinsic Value_3Y_max--5.045--------
Intrinsic Value_3Y_min--2.689--------
Intrinsic Value_5Y_max--10.040--------
Intrinsic Value_5Y_min--4.771--------
Market Cap4632303513.600-5%4868796306.7804710885705.698+3%4712191306.303+3%4172887554.720+17%5300211569.168-8%
Net Profit Margin--0.0930.079+17%0.077+21%0.080+16%0.066+40%
Operating Margin---0.023-100%0.107-100%0.087-100%0.047-100%
Operating Ratio--1.4081.447-3%1.464-4%1.454-3%1.037+36%
Pb Ratio1.608-5%1.6881.658+2%1.763-4%1.580+7%2.653-36%
Pe Ratio14.455-5%15.17815.791-4%18.235-17%16.429-8%38.725-61%
Price Per Share10.800-5%11.34010.968+3%10.970+3%9.723+17%12.354-8%
Price To Free Cash Flow Ratio6.510-5%6.8365.409+26%1.799+280%8.999-24%16.275-58%
Price To Total Gains Ratio30.903-5%32.448107.741-70%59.233-45%67.844-52%123.293-74%
Quick Ratio--0.2500.446-44%1.167-79%0.871-71%0.931-73%
Return On Assets--0.0180.017+3%0.018-1%0.019-4%0.016+11%
Return On Equity--0.0350.035+0%0.036-1%0.035-1%0.030+18%
Total Gains Per Share--0.3490.3500%0.272+28%0.250+40%0.244+43%
Usd Book Value--399108971.709393113126.990+2%369036279.450+8%365096452.792+9%308688125.552+29%
Usd Book Value Change Per Share--0.0320.019+71%0.008+295%0.010+239%0.014+127%
Usd Book Value Per Share--0.9300.915+2%0.859+8%0.851+9%0.719+29%
Usd Dividend Per Share--0.0160.030-45%0.030-45%0.025-36%0.020-18%
Usd Eps--0.0260.024+7%0.024+7%0.024+7%0.018+43%
Usd Free Cash Flow--24644584.31211561046.145+113%17884484.407+38%12245967.711+101%10886511.061+126%
Usd Free Cash Flow Per Share--0.0570.027+113%0.042+38%0.029+101%0.027+115%
Usd Free Cash Flow To Equity Per Share--0.057-0.007+113%0.009+530%0.003+2192%0.019+195%
Usd Market Cap641110806.282-5%673841408.858651986581.669+3%652167276.792+3%577527637.573+17%733549281.173-8%
Usd Price Per Share1.495-5%1.5691.518+3%1.518+3%1.346+17%1.710-8%
Usd Profit--11099280.52810842074.568+2%10381268.369+7%10455258.321+6%7802107.077+42%
Usd Revenue--119868672.045135294841.199-11%134618849.823-11%129121312.299-7%111754165.324+7%
Usd Total Gains Per Share--0.0480.0480%0.038+28%0.035+40%0.034+43%
 EOD+4 -4MRQTTM+24 -11YOY+25 -105Y+22 -1310Y+24 -11

3.2. Fundamental Score

Let's check the fundamental score of ZhuZhou QianJin Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.455
Price to Book Ratio (EOD)Between0-11.608
Net Profit Margin (MRQ)Greater than00.093
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.250
Current Ratio (MRQ)Greater than12.246
Debt to Asset Ratio (MRQ)Less than10.358
Debt to Equity Ratio (MRQ)Less than10.705
Return on Equity (MRQ)Greater than0.150.035
Return on Assets (MRQ)Greater than0.050.018
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of ZhuZhou QianJin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.011
Ma 20Greater thanMa 5010.484
Ma 50Greater thanMa 10010.138
Ma 100Greater thanMa 20010.643
OpenGreater thanClose10.610
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Interest Income  3,11812,93316,051-14,1781,87315,46617,338-71,750-54,411



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,490,339
Total Liabilities1,606,604
Total Stockholder Equity2,277,922
 As reported
Total Liabilities 1,606,604
Total Stockholder Equity+ 2,277,922
Total Assets = 4,490,339

Assets

Total Assets4,490,339
Total Current Assets3,397,799
Long-term Assets1,092,541
Total Current Assets
Cash And Cash Equivalents 1,685,549
Net Receivables 377,857
Inventory 561,970
Other Current Assets 66,954
Total Current Assets  (as reported)3,397,799
Total Current Assets  (calculated)2,692,330
+/- 705,469
Long-term Assets
Property Plant Equipment 586,443
Goodwill 14,074
Intangible Assets 222,748
Long-term Assets Other 22,127
Long-term Assets  (as reported)1,092,541
Long-term Assets  (calculated)845,391
+/- 247,149

Liabilities & Shareholders' Equity

Total Current Liabilities1,512,887
Long-term Liabilities93,717
Total Stockholder Equity2,277,922
Total Current Liabilities
Short Long Term Debt 48,606
Accounts payable 623,920
Other Current Liabilities 60,039
Total Current Liabilities  (as reported)1,512,887
Total Current Liabilities  (calculated)732,565
+/- 780,322
Long-term Liabilities
Long term Debt 10,000
Capital Lease Obligations Min Short Term Debt23,852
Long-term Liabilities Other 1,900
Long-term Liabilities  (as reported)93,717
Long-term Liabilities  (calculated)35,752
+/- 57,965
Total Stockholder Equity
Retained Earnings 1,017,785
Total Stockholder Equity (as reported)2,277,922
Total Stockholder Equity (calculated)1,017,785
+/- 1,260,137
Other
Capital Stock429,347
Common Stock Shares Outstanding 429,347
Net Invested Capital 2,336,529
Net Working Capital 1,884,911
Property Plant and Equipment Gross 586,443



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312002-12-312001-12-31
> Total Assets 
332,776
359,872
421,292
794,693
796,608
780,579
792,530
802,687
783,920
801,165
798,225
744,238
768,537
800,599
828,731
925,892
969,030
1,071,813
1,085,256
1,156,282
1,073,141
1,104,955
1,059,405
1,254,515
1,248,288
1,295,438
1,265,774
1,188,082
1,117,644
1,141,438
1,128,464
1,224,371
1,215,256
1,303,498
1,281,654
1,315,403
1,417,506
1,476,192
1,645,212
1,769,960
1,754,823
1,765,788
1,888,313
1,991,953
1,989,164
2,055,741
2,228,929
2,228,473
2,189,012
2,695,455
2,743,227
2,830,823
2,881,717
2,978,866
3,032,091
3,112,262
2,992,611
3,114,615
3,286,881
3,348,251
3,237,984
3,366,553
3,472,489
3,688,229
3,515,988
3,716,472
3,812,173
3,951,469
3,845,024
4,049,508
4,228,711
4,270,446
3,853,877
4,073,410
4,060,241
4,182,747
4,138,432
4,319,455
4,621,976
4,532,287
4,359,353
4,490,339
4,490,3394,359,3534,532,2874,621,9764,319,4554,138,4324,182,7474,060,2414,073,4103,853,8774,270,4464,228,7114,049,5083,845,0243,951,4693,812,1733,716,4723,515,9883,688,2293,472,4893,366,5533,237,9843,348,2513,286,8813,114,6152,992,6113,112,2623,032,0912,978,8662,881,7172,830,8232,743,2272,695,4552,189,0122,228,4732,228,9292,055,7411,989,1641,991,9531,888,3131,765,7881,754,8231,769,9601,645,2121,476,1921,417,5061,315,4031,281,6541,303,4981,215,2561,224,3711,128,4641,141,4381,117,6441,188,0821,265,7741,295,4381,248,2881,254,5151,059,4051,104,9551,073,1411,156,2821,085,2561,071,813969,030925,892828,731800,599768,537744,238798,225801,165783,920802,687792,530780,579796,608794,693421,292359,872332,776
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,380,192
2,515,825
2,596,320
2,792,764
2,630,530
2,827,241
2,955,282
3,100,927
2,981,457
3,196,401
3,189,349
3,188,686
2,760,919
2,948,198
2,917,258
3,046,577
3,019,725
3,208,148
3,513,492
3,429,983
3,266,658
3,397,799
3,397,7993,266,6583,429,9833,513,4923,208,1483,019,7253,046,5772,917,2582,948,1982,760,9193,188,6863,189,3493,196,4012,981,4573,100,9272,955,2822,827,2412,630,5302,792,7642,596,3202,515,8252,380,192000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
367,172
243,810
991,127
1,119,667
1,159,990
1,340,086
1,377,974
1,554,396
818,694
999,822
755,374
748,945
569,222
511,961
632,880
700,539
906,707
892,359
1,239,949
1,397,105
1,354,385
1,685,549
1,685,5491,354,3851,397,1051,239,949892,359906,707700,539632,880511,961569,222748,945755,374999,822818,6941,554,3961,377,9741,340,0861,159,9901,119,667991,127243,810367,172000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
360,000
64,000
64,000
887
2,000
0
0
0
566,067
425,007
652,252
551,638
544,612
744,008
736,836
676,155
558,954
542,277
491,744
150,279
50,325
0
050,325150,279491,744542,277558,954676,155736,836744,008544,612551,638652,252425,007566,0670002,00088764,00064,000360,000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
60,759
63,011
91,401
92,427
111,430
111,847
110,905
130,281
114,382
113,164
109,569
108,234
93,425
118,524
92,555
171,769
111,317
116,390
86,433
176,474
174,999
228,287
158,756
193,774
162,990
223,958
218,598
251,484
282,819
269,279
264,747
316,470
378,957
449,991
499,274
447,931
416,921
460,518
538,562
512,962
544,352
559,833
650,535
651,246
557,978
675,804
770,437
739,388
661,480
638,169
718,643
741,404
784,982
808,756
851,180
853,916
756,803
863,904
926,825
943,923
804,646
880,514
907,583
367,708
355,277
351,126
1,017,741
914,731
935,213
1,177,340
1,063,417
1,082,815
999,114
1,035,656
862,164
1,072,333
974,382
977,247
255,446
402,468
1,042,642
377,857
377,8571,042,642402,468255,446977,247974,3821,072,333862,1641,035,656999,1141,082,8151,063,4171,177,340935,213914,7311,017,741351,126355,277367,708907,583880,514804,646943,923926,825863,904756,803853,916851,180808,756784,982741,404718,643638,169661,480739,388770,437675,804557,978651,246650,535559,833544,352512,962538,562460,518416,921447,931499,274449,991378,957316,470264,747269,279282,819251,484218,598223,958162,990193,774158,756228,287174,999176,47486,433116,390111,317171,76992,555118,52493,425108,234109,569113,164114,382130,281110,905111,847111,43092,42791,40163,01160,759
       Other Current Assets 
17,527
6,223
10,886
16,256
23,691
24,968
36,227
38,108
44,618
38,366
25,112
23,982
28,721
27,860
14,036
28,450
27,003
24,410
15,230
46,476
26,316
29,703
25,982
28,773
41,551
55,300
32,007
34,749
33,224
53,627
30,397
47,923
38,126
58,167
29,124
87,230
161,492
206,734
78,730
95,531
96,866
121,221
98,110
132,066
161,918
163,287
123,944
134,393
130,255
467,546
171,564
204,551
231,258
508,533
136,203
597,230
141,564
255,354
145,124
319,191
103,044
640,810
83,706
101,798
27,174
18,871
80,041
131,637
158,185
105,210
120,591
238,595
60,765
155,114
82,216
82,458
57,295
270,065
198,911
166,716
71,243
66,954
66,95471,243166,716198,911270,06557,29582,45882,216155,11460,765238,595120,591105,210158,185131,63780,04118,87127,174101,79883,706640,810103,044319,191145,124255,354141,564597,230136,203508,533231,258204,551171,564467,546130,255134,393123,944163,287161,918132,06698,110121,22196,86695,53178,730206,734161,49287,23029,12458,16738,12647,92330,39753,62733,22434,74932,00755,30041,55128,77325,98229,70326,31646,47615,23024,41027,00328,45014,03627,86028,72123,98225,11238,36644,61838,10836,22724,96823,69116,25610,8866,22317,527
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
895,465
885,458
889,231
856,891
850,541
863,567
853,107
1,039,362
1,081,759
1,092,958
1,125,212
1,142,983
1,136,170
1,118,707
1,111,307
1,108,484
1,102,304
1,092,695
1,092,541
1,092,5411,092,6951,102,3041,108,4841,111,3071,118,7071,136,1701,142,9831,125,2121,092,9581,081,7591,039,362853,107863,567850,541856,891889,231885,458895,465000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
77,329
134,709
150,208
159,142
154,792
155,281
163,007
160,435
157,514
152,704
162,955
156,644
159,265
153,394
173,263
150,466
164,884
149,354
171,597
150,631
197,601
190,886
238,118
208,067
239,859
220,338
332,318
292,163
316,509
265,978
327,106
281,420
311,575
284,413
350,563
315,502
357,610
318,357
529,797
382,072
583,740
389,763
605,689
419,434
415,991
411,452
415,175
423,114
414,689
414,234
491,390
477,844
523,726
519,094
565,401
561,457
548,057
541,698
529,214
518,758
509,581
501,269
499,349
494,468
490,051
481,816
478,656
471,632
487,274
482,823
490,505
533,578
542,692
570,400
630,193
624,654
617,508
613,342
622,754
612,289
603,371
586,443
586,443603,371612,289622,754613,342617,508624,654630,193570,400542,692533,578490,505482,823487,274471,632478,656481,816490,051494,468499,349501,269509,581518,758529,214541,698548,057561,457565,401519,094523,726477,844491,390414,234414,689423,114415,175411,452415,991419,434605,689389,763583,740382,072529,797318,357357,610315,502350,563284,413311,575281,420327,106265,978316,509292,163332,318220,338239,859208,067238,118190,886197,601150,631171,597149,354164,884150,466173,263153,394159,265156,644162,955152,704157,514160,435163,007155,281154,792159,142150,208134,70977,329
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,074
14,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,07414,0740000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45,346
45,346
45,346
69,613
59,838
60,822
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000060,82259,83869,61345,34645,34645,346000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
4,612
4,492
4,610
4,539
4,644
4,539
4,585
4,477
1,406
4,430
1,440
4,475
1,257
4,561
1,471
28,764
1,586
28,877
1,937
28,757
2,077
28,635
2,150
55,578
4,899
54,894
2,114
56,186
19,242
55,490
4,707
54,887
16,108
54,197
4,541
53,648
4,373
54,170
4,256
270,541
57,108
267,904
43,931
265,423
263,905
262,517
261,356
260,047
258,883
257,540
274,491
273,022
272,003
270,652
271,812
270,347
268,720
268,765
236,239
234,696
219,444
218,299
232,620
285,487
93,447
291,923
255,232
254,751
226,649
225,747
216,421
216,125
214,698
217,739
219,634
218,307
219,091
220,289
221,827
220,730
220,082
222,748
222,748220,082220,730221,827220,289219,091218,307219,634217,739214,698216,125216,421225,747226,649254,751255,232291,92393,447285,487232,620218,299219,444234,696236,239268,765268,720270,347271,812270,652272,003273,022274,491257,540258,883260,047261,356262,517263,905265,42343,931267,90457,108270,5414,25654,1704,37353,6484,54154,19716,10854,8874,70755,49019,24256,1862,11454,8944,89955,5782,15028,6352,07728,7571,93728,8771,58628,7641,4714,5611,2574,4751,4404,4301,4064,4774,5854,5394,6444,5394,6104,4924,612
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
61,831
52,274
11,823
1,713
1,754
4,101
486,150
45,341
45,155
76,609
57,664
24,899
24,884
26,989
27,297
10,905
16,530
18,891
22,127
22,12718,89116,53010,90527,29726,98924,88424,89957,66476,60945,15545,341486,1504,1011,7541,71311,82352,27461,831000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
182,840
174,312
188,226
183,769
171,011
147,098
148,380
147,559
141,675
144,308
203,376
138,310
151,186
168,633
169,129
229,634
277,061
326,354
189,303
352,198
265,427
254,696
183,657
347,012
372,456
386,214
314,479
202,881
213,945
216,368
188,649
263,628
300,237
344,071
288,096
295,944
421,727
463,016
581,179
628,393
658,174
645,019
683,917
651,940
680,350
722,478
843,201
826,964
838,568
838,539
779,166
846,410
936,625
996,565
948,212
993,885
937,412
996,348
1,045,713
1,064,661
1,030,488
1,074,860
1,042,524
1,180,652
1,134,439
1,254,078
1,182,596
1,276,589
1,347,711
1,467,746
1,466,727
1,462,724
1,402,859
1,526,987
1,360,309
1,431,758
1,576,530
1,666,490
1,805,691
1,655,460
1,574,550
1,606,604
1,606,6041,574,5501,655,4601,805,6911,666,4901,576,5301,431,7581,360,3091,526,9871,402,8591,462,7241,466,7271,467,7461,347,7111,276,5891,182,5961,254,0781,134,4391,180,6521,042,5241,074,8601,030,4881,064,6611,045,713996,348937,412993,885948,212996,565936,625846,410779,166838,539838,568826,964843,201722,478680,350651,940683,917645,019658,174628,393581,179463,016421,727295,944288,096344,071300,237263,628188,649216,368213,945202,881314,479386,214372,456347,012183,657254,696265,427352,198189,303326,354277,061229,634169,129168,633151,186138,310203,376144,308141,675147,559148,380147,098171,011183,769188,226174,312182,840
   > Total Current Liabilities 
171,332
170,917
184,831
180,539
167,893
143,980
145,346
144,567
138,930
141,664
200,800
135,734
148,614
166,062
166,559
221,478
265,631
318,078
165,629
338,138
262,857
252,125
181,087
344,442
369,885
382,752
311,882
200,311
211,375
192,013
162,186
237,001
273,320
316,671
261,514
269,492
394,667
435,256
551,175
586,307
616,984
604,808
628,593
597,451
628,426
638,303
758,891
742,622
757,228
759,608
661,613
729,539
826,881
888,070
837,028
884,229
834,742
893,802
934,385
954,600
926,966
979,678
955,927
1,094,195
1,053,713
1,174,628
1,101,067
1,195,973
1,267,606
1,384,296
1,377,761
1,328,673
1,276,675
1,400,746
1,228,434
1,308,082
1,459,072
1,554,846
1,697,222
1,556,529
1,479,146
1,512,887
1,512,8871,479,1461,556,5291,697,2221,554,8461,459,0721,308,0821,228,4341,400,7461,276,6751,328,6731,377,7611,384,2961,267,6061,195,9731,101,0671,174,6281,053,7131,094,195955,927979,678926,966954,600934,385893,802834,742884,229837,028888,070826,881729,539661,613759,608757,228742,622758,891638,303628,426597,451628,593604,808616,984586,307551,175435,256394,667269,492261,514316,671273,320237,001162,186192,013211,375200,311311,882382,752369,885344,442181,087252,125262,857338,138165,629318,078265,631221,478166,559166,062148,614135,734200,800141,664138,930144,567145,346143,980167,893180,539184,831170,917171,332
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
1,000
1,000
1,000
1,000
938
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000009381,0001,0001,0001,0001,0001,000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
1,000
1,000
1,000
1,000
938
137,145
126,395
124,568
134,898
27,108
51,573
66,487
67,086
66,358
72,793
66,138
58,131
51,540
45,491
48,606
48,60645,49151,54058,13166,13872,79366,35867,08666,48751,57327,108134,898124,568126,395137,1459381,0001,0001,0001,0001,0001,000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
77,333
49,119
74,633
70,377
75,136
71,517
69,477
74,783
70,997
62,013
56,055
71,196
67,635
60,426
81,026
81,334
103,605
96,688
81,985
113,301
99,008
87,946
91,733
122,899
88,947
84,961
109,007
98,051
80,747
69,970
80,686
78,238
75,131
82,705
80,193
102,952
114,086
113,969
86,147
136,618
130,825
167,568
168,875
236,757
264,013
316,370
363,168
399,990
380,328
370,986
308,900
358,508
418,016
473,961
446,005
431,290
414,955
397,142
469,469
473,914
404,145
437,547
485,842
603,425
545,409
582,595
529,076
566,391
576,711
612,593
623,038
708,785
588,159
646,678
511,672
581,797
664,905
704,806
780,918
763,705
623,756
623,920
623,920623,756763,705780,918704,806664,905581,797511,672646,678588,159708,785623,038612,593576,711566,391529,076582,595545,409603,425485,842437,547404,145473,914469,469397,142414,955431,290446,005473,961418,016358,508308,900370,986380,328399,990363,168316,370264,013236,757168,875167,568130,825136,61886,147113,969114,086102,95280,19382,70575,13178,23880,68669,97080,74798,051109,00784,96188,947122,89991,73387,94699,008113,30181,98596,688103,60581,33481,02660,42667,63571,19656,05562,01370,99774,78369,47771,51775,13670,37774,63349,11977,333
       Other Current Liabilities 
92,475
88,998
77,098
96,162
78,757
72,463
63,869
69,784
67,933
79,651
144,745
64,538
80,979
105,636
85,533
140,144
162,026
171,390
83,644
224,837
163,849
164,179
89,354
121,543
149,938
166,791
71,875
102,260
130,628
122,043
81,500
158,763
198,189
213,966
181,321
166,540
273,081
313,787
349,128
349,689
431,159
382,240
372,718
222,694
284,413
260,932
334,723
304,631
314,901
329,023
349,602
370,131
408,866
414,109
390,523
452,439
418,787
495,661
463,916
479,686
299,330
501,316
239,266
1,000
1,000
1,000
363,563
467,384
387,418
591,158
393,288
546,165
402,600
611,059
360,711
600,474
468,815
708,401
87,989
62,568
460,191
60,039
60,039460,19162,56887,989708,401468,815600,474360,711611,059402,600546,165393,288591,158387,418467,384363,5631,0001,0001,000239,266501,316299,330479,686463,916495,661418,787452,439390,523414,109408,866370,131349,602329,023314,901304,631334,723260,932284,413222,694372,718382,240431,159349,689349,128313,787273,081166,540181,321213,966198,189158,76381,500122,043130,628102,26071,875166,791149,938121,54389,354164,179163,849224,83783,644171,390162,026140,14485,533105,63680,97964,538144,74579,65167,93369,78463,86972,46378,75796,16277,09888,99892,475
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86,457
80,726
79,450
81,529
80,616
80,105
83,450
88,966
134,051
126,184
126,241
131,876
123,676
117,458
111,644
108,469
98,930
95,404
93,717
93,71795,40498,930108,469111,644117,458123,676131,876126,241126,184134,05188,96683,45080,10580,61681,52979,45080,72686,457000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,000
-1,000
-1,000
-1,000
-1,000
-1,000
-938
0
0
0
0
46,529
42,246
37,963
44,787
39,043
35,369
32,442
32,764
25,467
23,700
23,852
23,85223,70025,46732,76432,44235,36939,04344,78737,96342,24646,5290000-938-1,000-1,000-1,000-1,000-1,000-1,000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,908
24,808
3,808
3,808
3,808
3,808
3,808
1,900
1,900
1,900
1,900
1,900
7,094
1,900
1,900
1,900
1,900
1,900
1,900
1,9001,9001,9001,9001,9001,9007,0941,9001,9001,9001,9001,9003,8083,8083,8083,8083,80824,80827,908000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,700
61,323
78,092
79,578
83,967
87,885
81,532
81,077
75,796
75,161
86,859
86,069
82,604
82,879
76,982
74,007
72,873
71,861
0
0
68,938
0
068,9380071,86172,87374,00776,98282,87982,60486,06986,85975,16175,79681,07781,53287,88583,96779,57878,09261,32356,700000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
135,386
165,820
216,933
593,759
609,229
618,635
630,623
641,306
628,454
641,686
578,486
589,380
600,830
615,006
640,575
676,507
672,944
726,797
874,642
782,985
787,152
828,602
851,405
882,776
852,047
883,938
924,027
957,661
874,525
895,357
901,574
922,049
872,721
882,284
908,293
934,233
910,570
928,910
966,035
986,444
936,500
957,842
1,008,209
1,086,715
1,054,735
1,078,983
1,121,452
1,141,800
1,097,569
1,605,518
1,646,818
1,668,385
1,633,471
1,662,255
1,745,666
1,773,793
1,722,417
1,774,978
1,877,407
1,911,352
1,841,566
1,915,084
2,028,834
2,096,152
1,968,492
2,044,363
2,178,082
2,215,815
2,049,533
2,132,282
2,266,772
2,304,692
1,951,827
2,037,498
2,150,385
2,190,369
2,022,575
2,100,802
2,216,215
2,263,922
2,194,068
2,277,922
2,277,9222,194,0682,263,9222,216,2152,100,8022,022,5752,190,3692,150,3852,037,4981,951,8272,304,6922,266,7722,132,2822,049,5332,215,8152,178,0822,044,3631,968,4922,096,1522,028,8341,915,0841,841,5661,911,3521,877,4071,774,9781,722,4171,773,7931,745,6661,662,2551,633,4711,668,3851,646,8181,605,5181,097,5691,141,8001,121,4521,078,9831,054,7351,086,7151,008,209957,842936,500986,444966,035928,910910,570934,233908,293882,284872,721922,049901,574895,357874,525957,661924,027883,938852,047882,776851,405828,602787,152782,985874,642726,797672,944676,507640,575615,006600,830589,380578,486641,686628,454641,306630,623618,635609,229593,759216,933165,820135,386
   Common Stock
38,000
38,000
38,000
56,000
56,000
56,000
56,000
56,000
84,000
84,000
84,000
84,000
126,000
126,000
126,000
126,000
151,200
151,200
151,200
151,200
181,440
181,440
181,440
181,440
217,728
217,728
217,728
217,728
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
304,819
348,756
348,756
348,756
348,756
348,756
348,756
348,756
348,756
348,756
348,756
348,756
418,507
418,507
418,507
418,507
418,507
418,507
418,507
418,507
418,507
418,507
418,507
418,507
418,507
418,507
418,507
429,807
429,807
429,807
0
0
429,507
0
0429,50700429,807429,807429,807418,507418,507418,507418,507418,507418,507418,507418,507418,507418,507418,507418,507418,507418,507418,507348,756348,756348,756348,756348,756348,756348,756348,756348,756348,756348,756304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819304,819217,728217,728217,728217,728181,440181,440181,440181,440151,200151,200151,200151,200126,000126,000126,000126,00084,00084,00084,00084,00056,00056,00056,00056,00056,00038,00038,00038,000
   Retained Earnings 
57,319
71,868
114,131
93,078
108,547
117,953
122,081
132,764
119,913
133,144
60,700
72,884
84,334
99,220
115,527
149,448
145,885
199,738
260,490
200,688
245,993
287,444
295,758
327,130
296,639
328,530
356,946
0
307,443
328,275
328,183
348,658
299,458
308,791
328,287
354,226
330,563
348,903
377,689
398,098
348,154
374,885
414,095
573,519
541,540
565,788
607,140
626,965
582,301
598,118
639,135
660,105
624,258
652,682
736,251
763,988
711,919
764,083
874,258
908,199
837,051
908,092
1,024,986
891,543
763,860
839,714
1,174,256
1,211,982
1,045,674
1,128,786
1,262,074
1,299,992
947,107
1,032,773
1,145,631
1,185,608
1,002,495
1,074,925
970,824
1,014,731
1,157,983
1,017,785
1,017,7851,157,9831,014,731970,8241,074,9251,002,4951,185,6081,145,6311,032,773947,1071,299,9921,262,0741,128,7861,045,6741,211,9821,174,256839,714763,860891,5431,024,986908,092837,051908,199874,258764,083711,919763,988736,251652,682624,258660,105639,135598,118582,301626,965607,140565,788541,540573,519414,095374,885348,154398,098377,689348,903330,563354,226328,287308,791299,458348,658328,183328,275307,4430356,946328,530296,639327,130295,758287,444245,993200,688260,490199,738145,885149,448115,52799,22084,33472,88460,700133,144119,913132,764122,081117,953108,54793,078114,13171,86857,319
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,627
-90
-77
-68
-63
-52
-51
749
751
751
752
753
757
1,553
1,553
0
0
1,402
0
01,402001,5531,553757753752751751749-51-52-63-68-77-9020,627000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,910,256
Cost of Revenue-2,165,214
Gross Profit1,745,0421,745,042
 
Operating Income (+$)
Gross Profit1,745,042
Operating Expense-3,495,055
Operating Income415,201-1,750,013
 
Operating Expense (+$)
Research Development142,867
Selling General Administrative968,692
Selling And Marketing Expenses-
Operating Expense3,495,0551,111,559
 
Net Interest Income (+$)
Interest Income22,895
Interest Expense-2,632
Other Finance Cost-16,112
Net Interest Income36,375
 
Pretax Income (+$)
Operating Income415,201
Net Interest Income36,375
Other Non-Operating Income Expenses-
Income Before Tax (EBT)463,921415,201
EBIT - interestExpense = -2,632
313,355
315,987
Interest Expense2,632
Earnings Before Interest and Taxes (EBIT)-466,553
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax463,921
Tax Provision-60,160
Net Income From Continuing Ops403,761403,761
Net Income313,355
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--36,375
 

Technical Analysis of ZhuZhou QianJin Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ZhuZhou QianJin Pharmaceutical Co Ltd. The general trend of ZhuZhou QianJin Pharmaceutical Co Ltd is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ZhuZhou QianJin Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ZhuZhou QianJin Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 10.87 < 10.95 < 11.02.

The bearish price targets are: 10.41 > 10.29 > 9.86.

Tweet this
ZhuZhou QianJin Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ZhuZhou QianJin Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ZhuZhou QianJin Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ZhuZhou QianJin Pharmaceutical Co Ltd. The current macd is 0.14568693.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the ZhuZhou QianJin Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for ZhuZhou QianJin Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the ZhuZhou QianJin Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ZhuZhou QianJin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhuZhou QianJin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ZhuZhou QianJin Pharmaceutical Co Ltd. The current adx is 19.40.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy ZhuZhou QianJin Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
ZhuZhou QianJin Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ZhuZhou QianJin Pharmaceutical Co Ltd. The current sar is 10.41.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
ZhuZhou QianJin Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ZhuZhou QianJin Pharmaceutical Co Ltd. The current rsi is 63.01. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
ZhuZhou QianJin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhuZhou QianJin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ZhuZhou QianJin Pharmaceutical Co Ltd. The current phase is Overbought in neutral market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the ZhuZhou QianJin Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
ZhuZhou QianJin Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhuZhou QianJin Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ZhuZhou QianJin Pharmaceutical Co Ltd. The current cci is 113.96.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
ZhuZhou QianJin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhuZhou QianJin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ZhuZhou QianJin Pharmaceutical Co Ltd. The current cmo is 34.39.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
ZhuZhou QianJin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhuZhou QianJin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ZhuZhou QianJin Pharmaceutical Co Ltd. The current willr is -13.46153846.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
ZhuZhou QianJin Pharmaceutical Co Ltd Daily Williams %R ChartZhuZhou QianJin Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ZhuZhou QianJin Pharmaceutical Co Ltd.

ZhuZhou QianJin Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ZhuZhou QianJin Pharmaceutical Co Ltd. The current atr is 0.22498483.

ZhuZhou QianJin Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhuZhou QianJin Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ZhuZhou QianJin Pharmaceutical Co Ltd. The current obv is 303,274,545.

ZhuZhou QianJin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhuZhou QianJin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ZhuZhou QianJin Pharmaceutical Co Ltd. The current mfi is 71.94.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
ZhuZhou QianJin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhuZhou QianJin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ZhuZhou QianJin Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

ZhuZhou QianJin Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ZhuZhou QianJin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.011
Ma 20Greater thanMa 5010.484
Ma 50Greater thanMa 10010.138
Ma 100Greater thanMa 20010.643
OpenGreater thanClose10.610
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of ZhuZhou QianJin Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on ZhuZhou QianJin Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ZhuZhou QianJin Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ZhuZhou QianJin Pharmaceutical Co Ltd

I send you an email if I find something interesting about ZhuZhou QianJin Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about ZhuZhou QianJin Pharmaceutical Co Ltd.

Receive notifications about ZhuZhou QianJin Pharmaceutical Co Ltd in your mailbox!